Drug diversion remains a major concern for hospital pharmacy teams and can cause increased risks for clinicians, patients and organizations. In response to the severity of the problem, pharmaceutical governing organizations will release new guidelines outlining best practices for diversion detection and investigations as well as a statement on the use of artificial intelligence in pharmacy.

This session will feature a panel discussion with diversion experts who will examine the problem of drug diversion and anticipated best practices for adhering to the pending guidelines.

MGMA tracked a year’s worth of data on physician and medical practice compensation, productivity, and more during 2020. Discover these insights to help chart your organization’s way forward. MGMA collected key financial and operational data throughout 2020 to discover the impact of the pandemic on providers and practices. Productivity and compensation dipped in the spring, yet recovery was not uniform. Practices also reported declining operating expenses commensurate with decreased patient volume. So, if financials and operations had a two-month hiccup, was the pandemic catastrophic for the viability of medical practices? Join us for a presentation of the data and a discussion about the key issues impacting this research. 

Read on mgma.com

SCCE & HCCA have partnered with the Committee of Sponsoring Organizations of the Treadway Commission (COSO) to create guidance on the application of the COSO’s Enterprise Risk Management (ERM) framework to the management of compliance risk. Published in November 2020, Compliance Risk Management: Applying the COSO ERM Framework, is based on current practices and expectations for effective compliance and ethics programs.

The guidance identifies 120 characteristics of effective compliance and ethics programs, with each characteristic mapped to the five components and 20 underlying principles of ERM.

We have developed a one-day virtual conference to assist in understanding and applying the guidance found in the publication. Sessions will be led by the publication authors, who are leaders in the compliance and ethics profession.

Join us as WEDI hosts a day-long examination of the Information Blocking Regulations. Attend sessions assessing your Go Live from April 5, listen to patient advocacy groups on how information blocking will address their day-to-day healthcare concerns, learn more about the information blocking exceptions, and learn about creating compliance from our expert panel.

Read on members.wedi.org

The pharmaceutical microbiology industry has seen many changes during the progression into the 21st century. With advances in rapid microbiological methods, revisions being made to regulations in the industry enhanced knowledge of the human microbiome, and novel testing methods this industry is ever-expanding.

Read on smi-online.co.uk

This session provides a basic overview of sex, gender, and sexual orientation through the use of key concepts and definitions. In addition, the barriers and impacts of sexual gender minorities are examined as well as the importance of inclusive language. These issues are further understood through the use of research examples and findings provided by The University of Victoria’s Dr. Francis Lao. Lastly, a basic understanding of MEDITECH and its approach to gender is reviewed.

Read on museweb.org

Amidst the COVID-19 Pandemic, Medical Device Marketers still face several challenges and are refining their marketing strategies throughout the remainder of the year. With trade shows canceled and face-to-face customer engagement is non-existent, medical device marketers are forced to figure out how to best market themselves in a virtual world while fine-tuning their 2021 budget.

This training program will discuss designing an effective cleanroom facility validation protocol and report, when and how to transition into the routine environmental monitoring processes, how to maintain a state of control within the cleanroom, and the routine environmental monitoring and excursion investigation processes.

Improving clinical documentation integrity (CDI) is a strategic necessity for healthcare organizations as it impacts far more than optimized claims processing: an accurate and complete clinical record supports patient care, quality outcomes, compliance, risk management, and revenue integrity. Additionally, driving clinically-focused CDI helps not only improve clinical documentation quality but also to get the complete medical picture of the patient, for better clinical outcomes.

Taking a closed-loop approach to CDI by leveraging advanced natural language understanding (NLU), healthcare organizations can effectively bridge workflow silos with shared clinical intelligence across front-end physician and back-end CDI processes. This enables them to meaningfully engage clinicians in the CDI process, prioritize and automate work for CDI specialists (CDIS), and improve overall clinical, financial, and operational outcomes.

We’re excited to share the details for the April 2021 Virtual HITMC (Healthcare and IT Marketing Community) event that will take place on April 28th, 2021 from 1:00 pm – 3:15 pm ET. We’re bringing back a reprise of what is probably the highest-rated session we’ve ever had at a HITMC event on the topic “Whole-Brain” Marketing.
Read on healthitmarketingconference.com